Europe versus the US: Research policy, research funding, research organization
-
Liechtenstein- und -von Hayek Saal
Plenary
/
German and English language
| |||||
| |||||
| |||||
|
BA, M.Sc., MBA Stephane HOGAN
Head of Unit for Biotechnology and Applied Genomics, DG Research, European Commission, Brussels
| Stéphane Hogan holds a BA in science (Genetics) and a Masters in Biotechnology from Trinity College Dublin in Ireland, as well as an MBA from the Open University. After several years in research and later in journalism, he worked for the Rhône-Poulenc group in France in the area of scientific communication, before joining the European Commission s DG Research in 1996. | |
| He is currently Head of Unit for Biotechnology and Applied Genomics, in the "Health" Directorate, which has the task of managing priority 1 - Life Sciences, Genomics and Biotechnology for Health - in the 6th Framework programme (2003-2006). | |
| The European Commission is now preparing the 7th Framework programme. In that context, the unit headed by Stéphane Hogan is focussed on establishing of a joint technology initiative for Innovative Medicines to tackle, in partnership with industry, the problem of drug development duration and cost. |
Helga NOWOTNY
Member, Austrian Council for Research and Technology Development; Chair, ERA Council Forum Austria, Vienna
| 1959 | Doctorate in Jurisprudence, University of Vienna |
| 1969 | Ph.D. in Sociology, Columbia University, New York |
| 1996-2002 | Professor of Philosophy and Science and Technology Studies, ETH Zurich |
| Teaching and Research Positions at the Institute for Advanced Study, Vienna; King's College, Cambridge; University of Bielefeld; Wissenschaftskolleg zu Berlin; Ecole des Hautes Etudes et Sciences Sociales, Paris; Science Center for Social Sciences, Berlin; Collegium Budapest | |
| 1998-2004 | Director, "Collegium Helveticum", ETH Zurich |
| 2001-2006 | Chair, EURAB - European Research Advisory Board of the European Commission |
| 2002-2004 | Director, Branco Weiss Fellowship Programme "Society in Science" |
| 2005-2011 | Chair, Scientific Advisory Board of the University of Vienna |
| 2007-2010 | Vice-President ERC - European Research Council |
| 2010-2013 | President, ERC - European Research Council |
| Professor em., Science and Technology Studies, ETH Zurich |
Dr. Heinrich M. SCHULTE
Geschäftsführer, Endokrinologikum Hamburg
| 1987 | Facharzt für Innere Medizin |
| Privatdozent, Habilitation, Venia Legendi für das Fach Innere Medizin | |
| Gastprofessur an der Medizinischen Fakultät Hangzhou, China | |
| 1992 | Berufung zum Universitätsprofessor (C3) der Universität Kiel |
| 1993-1999 | Geschäftsführender Direktor des IHF Institut für Hormon- und Fortpflanzungsforschung an der Universität Hamburg |
| 2001 | Gründung Endokrinologikum Hamburg |
| 2002-2005 | Präsident der European Society for Clinical Investigation, Brüssel |
Dr. Gernot TILZ
Head of the Clinical Immunology Unit, Jean Dausset Laboratorium, Karl-Franzens-Univeristät Graz
| 1959-1965 | Student at University of Graz, University of Paris and London, Conservatory and Academy of Music |
| Student of the Physician of Queen Elizabeth, The Dean of Westminster Medical School, Sir Richard Bayliss | |
| Graduation with distinction as "Doctor Medicinae Universae" at Graz University | |
| Demonstrator of Physiology, Assistant at Graz University, Pasteur Institute Paris, Professor of Medicine at Graz University Medical School | |
| Researcher at Scripps Clinic La jolla ( University of San Diego), University of Washington, London, Paris and Montpellier | |
| Founder of the hitherto non existing medical discipline Clinical Immunology in Graz, first bone transplanter in Austria with Mutz and Urban | |
| Head of the Clinical Immunology Unit, Jean Dausset Laboratorium |
